We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$2.09B
Cap. Flow
-$1.4B
Cap. Flow %
-8.24%
Top 10 Hldgs %
32.24%
Holding
303
New
25
Increased
89
Reduced
109
Closed
31

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$187M
2
APH icon
Amphenol
APH
+$160M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
FSLR icon
First Solar
FSLR
+$101M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$101M

Top Sells

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$783M
2
NVDA icon
NVIDIA
NVDA
+$273M
3
AMD icon
Advanced Micro Devices
AMD
+$178M
4
CRM icon
Salesforce
CRM
+$110M
5
CDNS icon
Cadence Design Systems
CDNS
+$96.6M

Sector Composition

Rank Sector Weight
1 Technology 45.69%
2 Healthcare 18.55%
3 Financials 15.91%
4 Communication Services 12.03%
5 Consumer Discretionary 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
151
Citigroup
C
$233B
$16.9M 0.1%
266,110
-998
-0.4% -$61.5K
GS icon
152
Goldman Sachs
GS
$285B
$16.7M 0.1%
36,972
-2,433
-6% -$1.07M
MNDY icon
153
monday.com
MNDY
$4.06B
$16.5M 0.1%
68,353
-262,072
-79% -$55.3M
ATR icon
154
AptarGroup
ATR
$7.87B
$16.3M 0.1%
115,464
-41,674
-27% -$6.03M
ROIV icon
155
Roivant Sciences
ROIV
$29.3B
$15.9M 0.09%
1,500,000
– –
TMUS icon
156
T-Mobile US
TMUS
$195B
$15.5M 0.09%
87,952
-842
-0.9% -$141K
ELVN icon
157
Enliven Therapeutics
ELVN
$3.94B
$15.2M 0.09%
+650,000
New +$13.7M
FWONK icon
158
Liberty Media Series C
FWONK
$23.7B
$14.6M 0.09%
203,088
-1,944
-0.9% -$137K
WOLF icon
159
Wolfspeed
WOLF
$1.24B
$14.6M 0.09%
640,000
-248,500
-28% -$6.43M
CVLT icon
160
Commault Systems
CVLT
$5.74B
$14.1M 0.08%
115,680
-19,724
-15% -$2.12M
SSNC icon
161
SS&C Technologies
SSNC
$18.8B
$14.1M 0.08%
224,298
-2,147
-0.9% -$133K
RXST icon
162
RxSight
RXST
$249M
$13.3M 0.08%
+220,607
New +$12.6M
JSPR icon
163
Jasper Therapeutics
JSPR
$21.4M
$13.2M 0.08%
+581,538
New +$13.9M
LFUS icon
164
Littelfuse
LFUS
$10.1B
$13M 0.08%
50,977
+2,436
+5% +$603K
DAWN
165
DELISTED
Day One Biopharmaceuticals
DAWN
$12.9M 0.08%
935,000
-250,000
-21% -$3.66M
FROG icon
166
JFrog
FROG
$11.5B
$12.9M 0.08%
342,621
-1,749,199
-84% -$64.1M
CNM icon
167
Core & Main
CNM
$7.44B
$12.7M 0.07%
258,889
-79,209
-23% -$4.4M
SYRE icon
168
Spyre Therapeutics
SYRE
$7.96B
$11.8M 0.07%
500,000
– –
VRDN icon
169
Viridian Therapeutics
VRDN
$2.46B
$11.6M 0.07%
889,198
– –
INFA
170
DELISTED
Informatica
INFA
$11.2M 0.07%
+362,416
New +$11.4M
IRON icon
171
Disc Medicine
IRON
$2.64B
$11M 0.07%
244,928
– –
LITE icon
172
Lumentum
LITE
$75.2B
$10.9M 0.06%
214,000
+86,000
+67% +$3.9M
OLMA icon
173
Olema Pharmaceuticals
OLMA
$892M
$10.8M 0.06%
1,000,000
+250,000
+33% +$2.71M
NVMI
174
Nova
NVMI
$10.6B
$10.6M 0.06%
45,090
-36,784
-45% -$7.28M
ARES icon
175
Ares Management
ARES
$29.7B
$10.5M 0.06%
78,986
+10,519
+15% +$1.44M
5 6
7
8 9

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Polar Capital Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, Polar Capital Holdings held 303 positions worth $17B, down 11% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Polar Capital Holdings withdrew a net $1.4B in Q2 2024, closing 31 positions and reducing 109 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in First Solar worth $105M.

  • Polar Capital Holdings's largest Q2 2024 buy was First Solar: 463,764 shares worth $105M.
  • Polar Capital Holdings added most to Broadcom in Q2 2024, an estimated $187M increase.
  • Polar Capital Holdings's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $273M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q2 2024, selling an estimated $783M.
  • Polar Capital Holdings's ten largest holdings make up 32% of its $17B portfolio in Q2 2024.
  • Polar Capital Holdings opened 25 new positions and closed 31 in Q2 2024.
  • Polar Capital Holdings's portfolio value fell 11% quarter-over-quarter to $17B.

Based on Polar Capital Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.